By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aduro Biotech 

626 Bancroft Way
Suite 3C
Berkeley  California  94710  U.S.A.
Phone: 510-848-4400 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy 7/21/2014 6:37:52 AM
Aduro Biotech Names Industry Veteran And Academic Leader, Gerald Chan, DSc To Its Board Of Directors 7/17/2014 8:05:29 AM
With Johnson & Johnson (JNJ) Deals, Berkeley's Aduro Biotech Gets New Chance To Prove Worth 6/18/2014 7:59:43 AM
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/11/2014 3:04:04 PM
Aduro Biotech Announces American Society of Clinical Oncology Presentation Of Promising Results From Phase 1b Clinical Trial Of Its Novel Immunotherapy For The Treatment Of Mesothelioma 6/2/2014 10:46:52 AM
Johnson & Johnson (JNJ)'s Janssen Biotech Inc. (JNJ) Licenses LADD From Bay Area's Aduro Biotech In Deal Worth $365 Million 5/29/2014 7:36:19 AM
Aduro Biotech Announces Pancreatic Cancer And Mesothelioma Abstracts To Be Presented At 2014 American Society of Clinical Oncology Annual Meeting 5/21/2014 6:34:05 AM
Aduro Biotech Announces Initation Of A Clinical Trial Of Its Novel Immunotherapy In Patients With Brain Cancer At Providence Cancer Center 5/5/2014 9:49:21 AM
Aduro Biotech Announces Initation Of A Clinical Trial Of Its Novel Immunotherapy In Patients With Brain Cancer At Providence Cancer Center 5/5/2014 8:50:00 AM
Aduro Biotech Announces Initiation Of Phase 2b ECLIPSE Trial To Evaluate Treatment Of Patients With Pancreatic Cancer With The Company’s Innovative Immunotherapies 2/10/2014 9:50:01 AM
1234
//-->